HAP Trading’s Altimmune ALT Stock Holding History

HAP Trading’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-80,200	Closed	-$6K	–	2503
2021 Q3	$6K	Buy	+80,200	New	+$975K	﹤0.01%	2132
2020 Q2	–	Sell	-12,000	Closed	-$13K	–	1658
2020 Q1	$13K	Buy	+12,000	New	+$27.6K	﹤0.01%	982

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

HAP Trading's ALT Position: Q2 2023 in Review

HAP Trading sold out of Altimmune (ALT) in Q2 2023, closing a stake of 52,113 shares — an estimated $220K sold.

HAP Trading first reported a position in ALT in Q3 2021 and held it in 2 quarters. The position peaked at $1.18M in Q3 2021. 120 funds tracked by Wall St. Rank hold ALT as of Q2 2023.

HAP Trading reported no remaining Altimmune position as of Q2 2023 after selling out during the quarter.
HAP Trading sold 52,113 Altimmune shares in Q2 2023, an estimated $220K.
HAP Trading first reported a position in Altimmune in Q3 2021 and held it in 2 quarters.
HAP Trading's Altimmune position peaked at $1.18M in Q3 2021.
120 funds tracked by Wall St. Rank held Altimmune as of Q2 2023.

Based on HAP Trading's 13F filing for Q2 2023, filed 11 Aug 2023.